Antibody Engineering & Therapeutics Europe 2026, Basel, Switzerland, May 27-29

Conference

Event
-
May 27, 2026

‍

Don't miss genOway's presentation:

‍

🕛 Friday, 29 May 2026 12:30 - 13:00

📍 Congress Center, Basel Switzerland

🎓 Presenter: Kader Thiam, CSO & SVP – Discovery, Preclinical Models & Services

📢 Presentation Title: Enhancing the Translational Relevance of Immunotherapies Efficacy and Safety in Preclinical Models

  • Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments, without side effects
  • Evidencing the recruitment of human immune cells to tumor microenvironment, as well as their activation status
  • Showcasing immunocompetent mouse models expressing humanized Fc receptors as tools for translational assessment of engineered antibodies

‍

Antibody Engineering & Therapeutics Europe 2026, Basel, Switzerland, May 27-29

Get in touch

Let us know how we can help

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tukuba, Japan, November 16-19, 2026
Conference
Event
-
Nov 2026
Read on
SITC meeting 2026, Phoenix, Arizona, November 4-8
Conference
genOway presentation
Event
-
Nov 2026
Read on
2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
AusBiotech International Conference 2026, Queensland, October 21-23, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe